Home » News » Awards & Advancement » Affymax names VP, clinical development

Affymax names VP, clinical development

Wednesday, August 3, 2011

Affymax has named Krishna Polu, M.D. vice president, clinical development. Dr. Polu, a nephrologist, joined Affymax in 2009 as executive director, clinical development.

Prior to joining Affymax, Dr. Polu was executive director, global development at Amgen where he was responsible for clinical programs in nephrology, diabetes and heart failure. He led the global clinical development programs for both EPOGEN and Aranesp while at Amgen. Before joining Amgen, he was a clinical and research fellow at Harvard Medical School in the Renal Division at Brigham and Women’s Hospital and Massachusetts General Hospital.


Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!